Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes Care 29:901-907, 2006
DOI: 10.2337/diacare.29.04.06.dc05-2011
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saely, C. H.
Right arrow Articles by Drexel, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saely, C. H.
Right arrow Articles by Drexel, H.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

Adult Treatment Panel III 2001 but Not International Diabetes Federation 2005 Criteria of the Metabolic Syndrome Predict Clinical Cardiovascular Events in Subjects Who Underwent Coronary Angiography

Christoph H. Saely, MD1,2, Lorena Koch, MD1, Fabian Schmid1, Thomas Marte, MD1,2, Stefan Aczel, MD1,2, Peter Langer, PHD1, Guenter Hoefle, MD2 and Heinz Drexel, MD1,2

1 Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
2 Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria

Address correspondence and reprint requests to Heinz Drexel, MD, Professor of Medicine, VIVIT, Carinagasse 47, A-6800 Feldkirch, Austria. E-mail: vivit{at}lkhf.at

OBJECTIVE—The International Diabetes Federation (IDF) has recently established a worldwide consensus definition of the metabolic syndrome. No prospective data are available on the cardiovascular risk associated with this new metabolic syndrome definition.

RESEARCH DESIGN AND METHODS—In a prospective study of 750 coronary patients, we recorded vascular events over 4 years.

RESULTS—From our patients, 37.3% (n = 280) had the metabolic syndrome according to the Adult Treatment Panel III (ATPIII) definition and 45.5% (n = 341) according to the IDF definition. The metabolic syndrome as defined by the ATPIII criteria significantly predicted vascular events (adjusted hazard ratio 1.745 [95% CI 1.255–2.427]; P = 0.001), but the metabolic syndrome as defined by IDF criteria did not (1.189 [0.859–1.646]; P = 0.297). Accordingly, event-free survival was significantly lower among patients who fulfilled the ATPIII but not the IDF criteria than among those who met the IDF but not the ATPIII criteria (P = 0.012). The metabolic syndrome as defined by ATPIII criteria remained significantly predictive of vascular events after adjustment for type 2 diabetes but not after additional adjustment for the metabolic syndrome components high triglycerides and low HDL cholesterol. These lipid traits in turn proved significantly predictive of vascular events even after adjustment for the metabolic syndrome.

CONCLUSIONS—The ATPIII definition of the metabolic syndrome confers a significantly higher risk of vascular events than the IDF definition. However, among angiographied coronary patients, even the ATPIII definition of the metabolic syndrome does not provide prognostic information beyond its dyslipidemic features.

Abbreviations: ATPIII, Adult Treatment Panel III • CAD, coronary artery disease • IDF, International Diabetes Federation


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
F.L.J. Visseren
Vascular consequences of metabolic syndrome in early life
Eur. Heart J., March 2, 2008; 29(6): 693 - 694.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A. M.J. Wassink, Y. van der Graaf, J. K. Olijhoek, F. L.J. Visseren, and for the SMART Study Group
Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm
Eur. Heart J., January 2, 2008; 29(2): 213 - 223.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. Iso, S. Sato, A. Kitamura, H. Imano, M. Kiyama, K. Yamagishi, R. Cui, T. Tanigawa, and T. Shimamoto
Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke Among Japanese Men and Women
Stroke, June 1, 2007; 38(6): 1744 - 1751.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. B. Meigs, M. K. Rutter, L. M. Sullivan, C. S. Fox, R. B. D'Agostino Sr., and P. W.F. Wilson
Impact of Insulin Resistance on Risk of Type 2 Diabetes and Cardiovascular Disease in People With Metabolic Syndrome
Diabetes Care, May 1, 2007; 30(5): 1219 - 1225.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. Pambianco, T. Costacou, and T. J. Orchard
The Prediction of Major Outcomes of Type 1 Diabetes: a 12-Year Prospective Evaluation of Three Separate Definitions of the Metabolic Syndrome and Their Components and Estimated Glucose Disposal Rate: The Pittsburgh Epidemiology of Diabetes Complications Study experience
Diabetes Care, May 1, 2007; 30(5): 1248 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin
Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes: "Double diabetes" in the Diabetes Control and Complications Trial
Diabetes Care, March 1, 2007; 30(3): 707 - 712.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.